Methods and means for regulation of gene expression
CA 2413468 A1 · Owner: Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. · Inventors: Cortese, Riccardo; Ciliberto, Gennaro; Toniatti, Carlo
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A transcription factor, which is a transcriptional activator or a transcriptional repressor, comprising a DNA-binding domain and a transcriptional activator or repressor domain and optionally a regulatory , domain for ligand-dependent DNA binding and/or transcriptional activation or repression by the transcription factor wherein the transcription factor is , chimeric comprising a HNF1 polypeptide DNA-binding domain and a transcriptional activator or repressor domain of a different polypeptide with , the proviso that where the transcription factor is a transcriptional activator comprising a transcriptional activator domain the transcription factor does not comprise a regulatory domain …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 15, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 15, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 15, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.